COMPANY
NOVARTIS PHARMACEUTICALS CANADA INC
NOVARTIS PHARMACEUTICALS CANADA INC: marketing authorisation holder for Calcitonin, Octreotide, as stated by public registers.
MARKETING AUTHORISATION HOLDER
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Calcitonin | MIACALCIN INJECTION 200IU/ML (DIN 02144301), Approved Regulator Health Canada |
|---|---|
| Calcitonin | MIACALCIN NASAL SPRAY 200 IU (DIN 02240775), Cancelled Post Market Regulator Health Canada |
| Octreotide | SANDOSTATIN (DIN 00839191), Marketed Regulator Health Canada |
| Octreotide | SANDOSTATIN (DIN 00839205), Cancelled Post Market Regulator Health Canada |
| Octreotide | SANDOSTATIN (DIN 00839213), Cancelled Post Market Regulator Health Canada |
| Octreotide | SANDOSTATIN (DIN 02049392), Cancelled Post Market Regulator Health Canada |
| Octreotide | SANDOSTATIN LAR (DIN 02239323), Marketed Regulator Health Canada |
| Octreotide | SANDOSTATIN LAR (DIN 02239324), Marketed Regulator Health Canada |
| Octreotide | SANDOSTATIN LAR (DIN 02239325), Marketed Regulator Health Canada |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.